Resources for News Media
The NCI press office is the central news contact for all members of the media. The office can assist you in arranging interviews with NCI researchers and in providing accurate and timely cancer research news and information.
For information about NCI's history and current activities, see NCI Overview and Budget and Appropriations.
Connect with Us
Our office hours are Monday through Friday, 9 a.m. to 5 p.m. ET.
Email: ncipressofficers@mail.nih.gov
Phone: 240-760-6600
Social Media:
@NCIMedia
NCI's YouTube Channel
Address:
Building 31, Room 10A25
31 Center Drive MSC 2580
Bethesda, MD 20892-2580
Recent Interviews from Scientists at NCI
-
Study uncovers clues to rise in uterine cancer death rates
May 5, 2022 | AP News
A rare but aggressive kind of uterine cancer appears to be driving an increase in U.S. deaths from the disease, particularly among Black women, researchers reported Thursday. -
Study: Black, Hispanic Women More Likely To Die From Uterine Cancer
May 5, 2022 | Newsy
More aggressive non-endometroid uterine cancer deaths increased by almost 3% per year. Black women face the harshest fatality rates. -
NCI Leaders Optimistic about Meeting President’s Goal
April 11, 2022 | Cancer Discovery
Current NCI Director Norman “Ned” Sharpless, MD, and Douglas Lowy, MD, who will become acting director following Sharpless’s departure from the institute at the end of April, are confident that the cancer community can reach President Joe Biden’s goal to cut deaths from cancer in half within 25 years. They identified several opportunities to improve cancer screening, prevention efforts, and treatment that could contribute to a declining death rate. -
NCI program to provide molecular characterization of childhood cancers
March 21, 2022 | Healio
Dr. Brigitte Widemann talks about the Molecular Characterization Initiative. -
Global Health and the National Cancer Institute
January 27, 2022 | That Medic Podcast
In this episode, we spoke to Dr. Satish Gopal, Director of the Center for Global Health at the National Cancer Institute. We discussed why students should care about global health, his experience as the only certified medical oncologist in Malawi, a country of 18 million, and how he is helping bridge disparities in the global cancer burden.
-
Black Women And The Breast Cancer Disparity
October 8, 2021 | Newsy
After years of spreading the same message, two women combined their efforts to help educate and support other Black women before and after diagnosis.
Trending Topics
-
Cancer Cabinet Community Conversations: Doubling Clinical Trials Accrual
The National Cancer Institute hosted a virtual roundtable titled “Cancer Cabinet Community Conversations: Doubling Clinical Trials Accrual” as part of a series of coordinated Cancer Cabinet Community Conversations on May 4, 2022, as part of the Cancer Moonshot Initiative. This is a recording on YouTube.
-
Uterine Cancer—Patient Version
Uterine cancers can be of two types: endometrial cancer (common) and uterine sarcoma (rare). Endometrial cancer can often be cured. Uterine sarcoma is often more aggressive and harder to treat. Start here to find information on uterine cancer treatment, causes and prevention, screening, research, and statistics.
-
White House Event: President Biden Hosts an Event at the White House to Reignite the Cancer Moonshot
Recording on YouTube of White House event
-
NCI COVID-19 in Cancer Patients Study (NCCAPS)
The NCI COVID-19 in Cancer Patients Study, or NCCAPS, is a natural history study of COVID-19 in people with cancer. The knowledge gained from this study will help doctors better manage treatment for people with cancer and COVID-19 in the future.
-
Immunotherapy to Treat Cancer
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. This page covers the types of immunotherapy, how it is used against cancer, and what you can expect during treatment.
Multimedia from NCI
Recent News Releases
-
Norman Sharpless steps down as director of the National Cancer Institute
Norman E. “Ned” Sharpless, M.D., announces his decision to step down as NCI director, a position he has held since 2017. NCI Principal Deputy Director Douglas R. Lowy, M.D., will serve as NCI’s acting director beginning April 30, 2022.
-
NCI launches program to offer molecular characterization of childhood cancers
The Molecular Characterization Initiative will offer state-of-the-art diagnoses to children, adolescents, and young adults with central nervous system tumors.
-
NCI study advances personalized immunotherapy for metastatic breast cancer
NCI researchers have shown that an experimental form of immunotherapy that uses an individual’s own tumor-fighting immune cells could potentially be used to treat people with metastatic breast cancer who have exhausted all other treatment options.